See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.57▲ 1.67%
← KAMBI page
XStocksXray
Market X-Ray report · 27 October 2026

Kambi Group PLC (KAMBI)

Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026

Key indicators

Last closeSEK 155.00
52-week range99.00 – 189.20
Return, 1 month / 3 months−6.7% / −14.3%
Return, 1 year / 3 years+30.8% / −0.8%
TrendAbove 200-day, below 50-day
RSI (14)36
Volatility (1 year)42.4%
Worst drawdown (1 year)-27.1%
Average daily value traded9.31M SEK
Dividend yield–

Market X-Ray price-based

71/ 100 · High confidence · ahead of 81% of stocks on this exchange
Trend77
Momentum67
Stability (higher is calmer)67
Liquidity78
Income–

Five-year price chart navy: price · brown: 200-day average

74.861261772292802021-102023-012024-042025-072026-10

About the company

Kambi Group supplies sports betting technology and services to licensed gambling operators. Its customers are betting and gaming companies that use the company's sportsbook platform, which covers odds compilation, trading and risk management, and related software. Kambi is based in Malta and serves operators in regulated markets internationally, working behind the scenes rather than running consumer-facing betting brands of its own.

The shares are listed on the Nasdaq Stockholm in Sweden under the code KAMBI, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Kambi Group PLC (KAMBI) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 155.00 on 27 October 2026.

Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 175 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 30.8% and over the last three months it fell 14.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Kambi Group PLC (KAMBI)

The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm

Lens and metricValueScoreReading
Trend77 · StrongTrading above its long-term averages and near its highs.
Above 200-day average4.5%
From 52-week high-17.0%
Momentum67 · FairTypical recent returns for this exchange.
3-month return-14.3%
6-month return19.8%
12-month return, skipping the last month40.3%
Stability (higher is calmer)67 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)42.4%
Worst drawdown, 1 year (smaller is calmer)-27.1%
Liquidity78 · StrongTrades actively.
Average daily value traded9.31M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week+0.5%
1 month−6.7%
3 months−14.3%
6 months+19.8%
1 year+30.8%
3 years−0.8%
5 years−29.4%

Signals

50-day / 200-day average169.58 / 148.35
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.99

Technical summary

DailyBearish2 bullish · 4 neutral · 10 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026